On Aug 19, Snyder Douglas B., Chief Legal Officer sold 5,424 shares of GW Pharmaceuticals plc (NASDAQ: GWPH), with the average selling price of the stock being $13.04 per share. The total amount realized from this sold $70,729. A document was filed with the Securities and Exchange Commission to notify the public about the sold of the shares.
In addition to that, Chief Legal Officer – Snyder Douglas B. sold an extra 3,756 shares of this stock in a transaction that took place a day before, on Aug 12, with a share sold at an average of $13.88 and a total of $52,133 was realized from this transaction. After the transaction, the Chief Legal Officer – Snyder Douglas B. was left with 79,164 shares of the company’s stock, which is currently worth around $1098796.32.
The recent price movement of GWPH means that it is now down by -44.18% from its 52-week high and 21.38% up against its 52-week low prices. Over the past one week, the price volatility of GWPH stands at 5.30% while the volatility over the past one month is 4.56%. The beta score for this stock is 2.26. A beta score below 1 means that the stock has a low volatility while above 1 signifies that a stock is highly volatile at that particular moment, a data that traders use to keep tabs on their investments.
The company on 11/05/2019 published its latest quarterly earnings, with the report showing that the company recorded -2.76 earnings per share (EPS) during that period. This report was below the expectations of analysts of -2.51 by -0.25. The revenue by the firm was 85.32M for the quarter.
The shares of GW Pharmaceuticals plc (GWPH) gained by 0.34%, leading to a gain of $0.37 per share, and saw GWPH end the trading session at $109.41 on Friday 11/08/19. GWPH started the trading session at $108.81, before reaching a daily high of $111.4411. It wasn’t able to sustain that growth though and soon jumped to hit a daily low of $106.52.
The trading volume on Friday stood at 1851335, which was below the stock’s 3-month average volume of 649.28K shares, out of a total 2.24M shares. As the price of the stock climbed, the market valuation of the company gained to 3.37 billion.
The shares of VEREIT Inc. (NYSE: VER) went up by 0.32% by the end of the recent trading session. This movement saw its price surge to close at $9.39, which was higher than the previous closing price of $9.36. Over the past one week, the price of VER has slipped by -4.38%, while it has recorded a loss of -3.69% over the past one month. Its three-month performance saw VER lose -1.78% while its six-month performance saw it surge by 10.86%. The situation is different though over the past one year, as the stock price went up by 24.04%, while its year-to-date (YTD) price performance jumped by 31.33%. The stock price has gone up by +1.08% compared to its 90-day low, while it is down -7.31% compared to its 90-day high price.
Let’s take a look at its short, medium and long-term indicators. Composite Indicators shows that Trendspotter rated the stock as a Sell. In the short-term, the stock has a 20-day average volume of 11,860,040 shares, with the short-term indicators averagely rating the stock as a Hold. A look at its medium-term indicators reveals that it has a 50-Day average volume of 15,401,178 shares and the indicators have an average rating of 50% Buy. The last indicators, the long-term see VER stock with a 100-Day average volume of 12,544,001 shares, giving it an average rating of 50% Buy. A look at the general picture of all short, medium and long-term indicators leaves VER with an average rating of 24% Buy.
Several brokerage firms sent out their reports VER stock not long ago. In its report sent out on October 25, 2019, BMO Capital Markets lowered its ratings on VER to a Outperform. In an earlier report on September 30, 2019, Evercore ISI Upgrade the stock from a In-line to a Outperform. Evercore ISI meanwhile in its report on September 30, 2019 Downgrade its rating of the stock from a “In-line” to “In-line”.
In related news to the company’s stock, around 89.30% shares are being held by institutional investors. In a recent SEC filing, the company revealed that 469 institutions currently hold the VER stock. In the last quarter, a 944,202,514 VER shares were in the possession of institutions. On the other hand, the company recorded 59 new institutions who bought it their stock, while 45 institutions sold their entire VER reserve. Of the current institutions investing in the stock, 210 increased their investment while 171 decreased their investment in the stock.